Loading...

Home
ETF
NGNE

NGNE

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

NGNE News

Neurogene Prices Public Offering of 3.5M Shares at $30 Each

Jul 01 2026seekingalpha

Neurogene Launches Public Offering to Fund NGN-401 Development

Jun 30 2026seekingalpha

Neurogene Reports Positive Long-Term Data for NGN-401 in Rett Syndrome

Jun 29 2026NASDAQ.COM

Neurogene Exceeds Dosing Target in NGN-401 Trial

Jun 08 2026Newsfilter

Neurogene Q1 Earnings Miss Expectations with GAAP EPS of -$1.39

May 12 2026seekingalpha

Neurogene Advances Gene Therapy with ICV Administration

May 12 2026Newsfilter

Neurogene Advances Gene Therapy for CNS Diseases

Apr 28 2026Newsfilter

Neurogene Reports FY GAAP EPS of -$4.24, Exceeding Expectations

Mar 24 2026seekingalpha

Neurogene Reports 2025 Financial Results and Updates

Mar 24 2026Newsfilter

NEUROGENE INC - FULL ENROLLMENT ACHIEVED AND OVER 50% DOSING IN EMBOLDEN TRIAL; EXPECTED TO FINISH DOSING BY Q2 2026

Mar 24 2026moomoo

NEUROGENE REPORTS FY NET INCOME OF -$90.351 MILLION

Mar 24 2026moomoo

NEUROGENE REPORTS FY OPERATING LOSS OF USD 103.328 MILLION

Mar 24 2026moomoo

Neurogene to Participate in Stifel 2026 Virtual CNS Forum

Mar 11 2026Newsfilter

Yatsen Holding Reports Q4 Earnings Decline

Mar 02 2026Benzinga

U.S. Stocks Decline Midway; Dell Shares Surge Over 21%

Feb 27 2026Benzinga

Autodesk Reports Strong Q4 Earnings, Raises Guidance

Feb 27 2026Benzinga